Sue Decotiis, MD

Vivus Expectations Drop Its Shares 10.15.12 FrenchTribune.com Vivus Inc.’s (US: vvus) expectations on Friday suddenly let it shares down by 12%, a recent report has uncovered. It had expressed estimations that European regulators might recommend that its Qsymia drug should not be approved by the US Food and Drug Administration. However, shares of other firms either manufacturing […]